Genetic susceptibility to neonatal infection

Current Opinion in Infectious Diseases

Volumn 19, Issue 3, 2006, Pages 259-263

  Strunk, Tobias ^a   Burgner, David ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cytokine; Genetic; Infection; Neonate; Susceptibility

Indexed keywords

CD14 ANTIGEN; CYTOKINE; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

CHORIOAMNIONITIS; COST OF ILLNESS; CYTOKINE PRODUCTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; IMMUNE SYSTEM; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; MATURATION; NEWBORN; NEWBORN INFECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; PREMATURE LABOR; REVIEW; RISK FACTOR; SEPSIS; TH1 CELL; TH2 CELL;

COMMUNICABLE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646674865     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000224820.19858.7a     Document Type: Review

References (60)

1. Lawn JE, Cousens S, Bhutta ZA, et al. Why are 4 million newborn babies dying each year? Lancet 2004; 364:399-401.
2. Kramer MS, Demissie K, Yang H, et al. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA 2000; 284:843-849.
3. Elder DE, Hagan R, Evans SF, et al. Hospital admissions in the first year of life in very preterm infants. J Paediatr Child Health 1999; 35:145-150.
4. Burgner D, Levin M. Genetic susceptibility to infectious diseases. Pediatr Infect Dis J 2003; 22:1-6.
5. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16:593-617.
6. El Beitune P, Duarte G, Maffei CM. Colonization by Streptococcus agalactiae during pregnancy: maternal and perinatal prognosis. Braz J Infect Dis 2005; 9:276-282.
7. Farquhar C, John-Stewart GV. The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol 2003; 134:367-377.
8. Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines, gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 2005; 118:1604-1609.
9. Kotiranta-Ainamo A, Apajasalo M, Pohjavuori M, et al. Mononuclear cell subpopulations in preterm and full-term neonates: independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal beta-methason therapy, and mode of delivery. Clin Exp Immunol 1999; 115:309-314.
10. Gasparoni A, Ciardelli L, De Amici D, et al. Effect of general and epidural anaesthesia on thyroid hormones and immunity in neonates. Paediatr Anaesth 2002; 12:59-64.
11. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004; 190:1509-1519.
12. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 2004; 190:147-151.
13. Park JS, Romero R, Yoon BH, et al. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol 2001; 185:1156-1161.
14. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995; 333:1737-1742.
15. Scannapieco FA, Bush RB, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcomes: a systematic review. Ann Periodontol 2003; 8:70-78.
16. Lopez NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res 2002; 81:58-63.
17. Lopez NJ, Da Silva I, Ipinza J, Gutierrez J. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy-associated gingivitis. J Periodontol 2005; 76:2144-2153.
18. Zhao Y, Dai ZP, Lv P, Gao XM. Phenotypic and functional analysis of human T lymphocytes in early second- and third-trimester fetuses. Clin Exp Immunol 2002; 129:302-308.
19. Kallman J, Schollin J, Schalen C, et al. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1998; 78:F46-F50.
20. Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate 2003; 84:297-303.
21. Strunk T, Temming P, Gembruch U, et al. Differential maturation of the innate immune response in human fetuses. Pediatr Res 2004; 56:219-226.
22. Yuan W, Basso O, Sorensen HT, Olsen J. Indicators of fetal growth and infectious disease in childhood: a birth cohort with hospitalization as outcome. Eur J Epidemiol 2001; 17:829-834.
23. Macaubas C, de Klerk NH, Holt BJ, et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet 2003; 362:1192-1197.
24. Siltanen M, Kajosaari M, Pohjavuori M, Savilahti E. Prematurity at birth reduces the long-term risk of atopy. J Allergy Clin Immunol 2001; 107: 229-234.
25. Hagberg H, Wennerholm UB, Savman K. Sequelae of chorioamnionitis. Curr Opin Infect Dis 2002; 15:301-306.
26. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182:675-681.
27. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003; 83:85-96.
28. Vigneswaran R. Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 2000; 36:293-296.
29. Schultz C, Rott C, Temming P, et al. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51:317-322.
30. Fotopoulos S, Mouchtouri A, Xanthou G, et al. Inflammatory chemokine expression in the peripheral blood of neonates with perinatal asphyxia and perinatal or nosocomial infections. Acta Paediatr 2005; 94:800-806.
31. Schultz C, Temming P, Bucsky P, et al. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004; 135:130-136.
32. Ellison VJ, Mocatta TJ, Winterbourn CC, et al. The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn. Pediatr Res 2005; 57:282-286.
33. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292:2357-2365.
34. Neufeld MD, Frigon C, Graham AS, Mueller BA. Maternal infection and risk of cerebral palsy in term and preterm infants. J Perinatol 2005; 25:108-113.
35. Nelson KB, Grether JK, Dambrosia JM, et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003; 53:600-607.
36. Levy O, Zarember KA, Roy RM, et al. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004; 173:4627-4634.
37. Bessler H, Osovsky M, Sirota L. Association between IL-1 ra gene polymorphism and premature delivery. Biol Neonate 2004; 85:179-183.
38. Lorenz E, Hallman M, Marttila R, et al. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002; 52:373-376.
39. Kalish RB, Vardhana S, Gupta M, et al. Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations. Am J Obstet Gynecol 2004; 190:702-706.
40. Hartel C, Finas D, Ahrens P, et al. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 2004; 10:911-915.
41. Ahrens P, Kattner E, Kohler B, et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 2004; 55:652-656.
42. Annells MF, Hart PH, Mullighan CG, et al. Polymorphisms in immunoregulatory genes and the risk of histologic chorioamnionitis in Caucasoid women: a case control study. BMC Pregnancy Childbirth 2005; 5:4. This paper demonstrates that polymorphisms in immunoregulatory genes IL-10, MBL2 (mannose-binding lectin), TNFRSF6 (tumour necrosis factor receptor family, member 6), and TGFB1 (transforming growth factor-(1) may influence susceptibility to chorioamnionitis.
43. Macones GA, Parry S, Elkousy M, et al. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004; 190:1504-1508; discussion 3A.
44. Hedberg CL, Adcock K, Martin J, et al. Tumor necrosis factor alpha -308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J 2004; 23:424-428.
45. Moore S, Ide M, Randhawa M, et al. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG Int J Obstet Gynaecol 2004; 111:125-132.
46. Harding D, Dhamrait S, Millar A, et al. Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infants? Pediatrics 2003; 112:800-803.
47. Schluter B, Raufhake C, Erren M, et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002; 30:32-37.
48. Kilpinen S, Hulkkonen J, Wang XY, Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw 2001; 12:62-68.
49. Endler G, Marsik C, Joukhadar C, et al. The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 2004; 50:195-200.
50. Heesen M, Kunz D, Bachmann-Mennenga B, et al. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta Ncol polymorphisms: association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 2003; 31:211-214.
51. Bokodi G, Treszl A, Derzbach L, et al. The association of the carrier state of the tumor necrosis factor-alpha (TNFalpha) -308A allele with the duration of oxygen supplementation in preterm neonates. Eur Cytokine Netw 2005; 16:78-80. This paper demonstrates that TNF genotype may be associated with adverse neonatal respiratory function.
52. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174:878-880.
53. Gopel W, Hartel C, Ahrens P, et al. Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants. Genes Immun 2006; 7:65-68. This study could not substantiate the role of the IL-6 polymorphism in the risk of developing sepsis in very low birth weight infants.
54. Hatzidaki E, Gourgiotis D, Manoura A, et al. Interleukin-6 in preterm premature rupture of membranes as an indicator of neonatal outcome. Acta Obstet Gynecol Scand 2005; 84:632-638.
55. Treszl A, Kocsis I, Szathmari M, et al. Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003; 83:241-245.
56. Gene MR, Vardhana S, Delaney ML, et al. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004; 116:152-156.
57. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-192.
58. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162:1028-1032.
59. Smirnova I, Mann N, Dols A, et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A 2003; 100:6075-6080.
60. LeVan TD, Guerra S, Klimecki W, et al. The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes Immun 2006; 7:77-80.